RLS Global, and ConvaTec have made continued progress with the distribution and commercialisation of ChloraSolv® in Europe. After intensive market preparation and work with specialist wound experts in the Netherlands, ChloraSolv® gel was listed on January 1, 2022 in the Z- index and received a positive recommendation for reimbursement from Zorginstituut Nederland (ZN). Chlorasolv® is already available in other European markets such as the Nordic countries.